PHARMA

0.245

+0.005 (+2.1%)

SUBDIVISION / CONSOLIDATION OF SHARES (CHAPTER 13 OF LISTING REQUIREMENTS) PHARMANIAGA BERHAD ("PHARMANIAGA" OR THE "COMPANY") PROPOSED CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIAGA ("PHARMANIAGA SHARE(S)") OR "SHARE(S)") INTO 1 PHARMANIAGA SHARE ("CONSOLIDATED SHARE(S)") ("PROPOSED SHARE CONSOLIDATION")

PHARMANIAGA BERHAD

Type Announcement
Subject SUBDIVISION / CONSOLIDATION OF SHARES (CHAPTER 13 OF LISTING REQUIREMENTS)
Description 
PHARMANIAGA BERHAD ("PHARMANIAGA" OR THE "COMPANY")

PROPOSED CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIAGA ("PHARMANIAGA SHARE(S)") OR "SHARE(S)") INTO 1 PHARMANIAGA SHARE ("CONSOLIDATED SHARE(S)") ("PROPOSED SHARE CONSOLIDATION")

On behalf of the Board of Directors of Pharmaniaga ("Board"), Affin Hwang Investment Bank Berhad ("Affin Hwang IB") wishes to announce that the Company is proposing to consolidate every 5 existing Pharmaniaga Shares held by the shareholders of Pharmaniaga, on an entitlement date to be determined and announced later, into 1 Consolidated Share.

 

Further details on the Proposed Share Consolidation are set out in the attachment enclosed.

 

This announcement is dated 7 April 2026.


Please refer attachment below.

Attachments

Pharmaniaga Berhad - Initial Announcement.pdf
280.5 kB


Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 07 Apr 2026
Category General Announcement for PLC
Reference Number GA1-06042026-00056


View original announcement